Clinical trial
Comparison of Efficacy of Topical Westerhoff Formula Cream Vs Topical 4% Hydroquinone for the Treatment of Melasma
NCT07508098 is registered in ClinicalTrials.gov with Pak Emirates Military Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of Efficacy of Topical Westerhoff Formula Cream Vs Topical 4% Hydroquinone for the Treatment of Melasma
- Lead sponsor
- Pak Emirates Military Hospital
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- July 18, 2025
- Completion date
- January 19, 2026
- Enrollment
- 50 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
melasma (facial melasma)